CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double Blind, Single Dose, Two Treatment, Two Period Crossover Pharmacokinetic Study Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®) in Healthy Volunteers

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02291445
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:19.992664+00:00
Published At: 2022-01-24T00:00:00+00:00
Record Updated At: 2022-01-24
Results Posted At: 2022-01-24
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Irritable Bowel Syndrome", "Abdominal Pain", "Colonic Diseases", "Visceral Pain"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-01-24"
protocolSection.identificationModule.nctId: "NCT02291445"
protocolSection.identificationModule.officialTitle: "A Randomized, Double Blind, Single Dose, Two Treatment, Two Period Crossover Pharmacokinetic Study Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse\u00ae) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol\u00ae) in Healthy Volunteers"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2022-01-24"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.